AR and urinary bladder carcinoma: Nonetheless, CGP46381 treatment in three AR-positive bladder cancer cell lines, as well as GABBR2 knockdown in UMUC3 cells, did not significantly change their proliferation (via MTT assay (Figure 4)) or migration (via wound-healing assay (Figure 5)).